In multiple carcinoma, melanoma, and leukemia cells, BASP1 transcription is silenced by promoter methylation (Kaehler et al., 2015; Moribe et al., 2008; Zhou et al., 2018), a typical DNA modification in the regulatory regions of tumor suppressors in cancer. Here, BASP1 is linked to neoplasm.